Vaccine development remains a balancing act. Each initiative begins with a careful risk-benefit analysis, and the stakes – life and death – could not be higher.
In coronavirus vaccine race, past missteps serve as cautionary tales
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over